Crossmark

CYP2C9*3 Increases the Ibuprofen Response of Hemodynamically Significant Patent Ductus Arteriosus in the Infants with Gestational Age of More Than 30 Weeks

Crossref DOI link: https://doi.org/10.1007/s43657-021-00028-9

Published Online: 2021-11-11

Published Print: 2022-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Chen, Xiang

Chen, Yuxi

Xiao, Tiantian

Dong, Xinran

Lu, Yulan

Qian, Yanyan

Wang, Huijun

Zhou, Wenhao
License Information

Text and Data Mining valid from 2021-11-11

Version of Record valid from 2021-11-11
More Information

Article History

Received: 26 March 2021

Revised: 27 September 2021

Accepted: 30 September 2021

First Online: 11 November 2021

Declarations

:

: The authors have no conflicts of interest to disclose.

: This study was approved by The China Neonatal Genomes Project (CNGP, ClinicalTrials.gov Identifier: NCT03931707) and the ethics committees of Children’s Hospital, Fudan University. The criteria for genetic testing were approved by ethics committees of Children’s Hospital, Fudan University (2014-107).

: The informed consent was in the written from and was obtained from all participants.

: Not applicable.

Document is current

Any future updates will be listed below